Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (IPS-I)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Holaira
ClinicalTrials.gov Identifier:
NCT01483534
First received: November 29, 2011
Last updated: September 22, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Publications: